- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
AIIMS Delhi introduces free drug monitoring tests for epilepsy patients

AIIMS
New Delhi: The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy from January 1, significantly reducing the need for testing at private laboratories, the institute said.
Epilepsy is a chronic brain disorder causing recurrent seizures, which are sudden bursts of abnormal electrical activity, leading to symptoms like muscle jerking, confusion, loss of awareness, or psychological changes.
In a statement, AIIMS explained that the drug monitoring test will measure the concentration of specific medications in a patient’s blood. This will ensure the dosage is both safe and effective, news agency IANS reported.
Also Read:AIIMS expert warns of rising mental health disorders among children
“Epilepsy patients are prescribed several medications, and AIIMS has decided to provide free testing facilities for monitoring phenobarbital, carbamazepine, valproic acid, and phenytoin,” the statement said.
“The therapeutic drug monitoring tests are conducted to measure the levels of these drugs in the blood. This allows for the evaluation of the drug’s effectiveness and helps in determining the appropriate dosage. This test also checks for any potential drug toxicity,” it added.
The institute noted that with the new facility, patients will no longer need to go outside for testing and will not have to pay any fees. Earlier, patients were required to spend between Rs 390 and Rs 1,880 for therapeutic drug monitoring tests for different medications at outside facilities.
In a circular dated January 1, undersigned by Prof. Nirupam Madaan, Medical Superintendent, the AIIMS administration issued instructions to all departments and centres, including the National Cancer Institute (NCI), to send patient samples to the designated laboratory for testing, reports IANS.
Both inpatients and outpatients can avail of this testing facility, the institute said.
The service will be available to AIIMS Delhi OPD patients at Collection Centre Room Number 3 from 8:30 AM to 1:00 PM, and also at the National Cancer Institute at AIIMS Jhajjar.
Kajal Rajput joined Medical Dialogues as an Correspondent for the Latest Health News Section in 2019. She holds a Bachelor's degree in Arts from University of Delhi. She manly covers all the updates in health news, hospitals, doctors news, government policies and Health Ministry. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

